Figure 3From: Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit? Percentage decrease (-)/increase (+) of sPGE2 in 30 patients 4 weeks post BoNT-A treatment (red lines: non responders to BoNT-A). Back to article page